乐普医疗：2025年净利同比预增224%~386%

Core Viewpoint - Lepu Medical (300003.SZ) expects a net profit attributable to shareholders of 800 million to 1.2 billion yuan for 2025, representing a year-on-year growth of 223.97% to 385.95% [1] Group 1: Business Performance - The growth is primarily driven by steady increases in the cardiovascular interventional business and the completion of inventory clearance in the pharmaceutical retail channel, leading to double-digit growth in formulation revenue [1] - Contributions from innovative drugs and emerging sectors such as dermatology are also significant [1] Group 2: Financial Developments - The company received a $30 million upfront payment for the MWN105 project under a licensing agreement [1] Group 3: Cost Management - Personnel optimization and organizational restructuring have led to a decrease in sales and management expenses [1]